Viewing nowDapaglin 10 mg (Dapagliflozin Bise L-Proline)
Dapagliflozin Bis L-proline 15.63mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

MFDS item code 202003739 · Approved 2020.05.22 · Insurance code 648104530
Improvement of blood glucose control in type 2 diabetes mellitus; prevention of worsening chronic kidney disease and heart failure
This medication is used to help control blood sugar levels in patients with type 2 diabetes. It is administered alone or in combination with diet and exercise therapy to improve blood sugar control. It also helps reduce the risk of death and hospitalization due to cardiovascular disease in patients with chronic heart failure. This medication is used alongside other standard heart failure treatments to prevent the worsening of heart failure. In patients with chronic kidney disease, it is effective in reducing the deterioration of kidney function and the risk of kidney-related death. Overall, this medication is used for the treatment of type 2 diabetes, chronic heart failure, and chronic kidney disease.
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received drug treatment for diabetes, when administered in combination with metformin, the recommended initial dose of this medicine is 5mg once daily or 10mg once daily. Chronic heart failure and chronic kidney disease The recommended dose of this medicine is 10 mg once daily. Special populations Renal impairment - eGFR below 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - eGFR below 25 mL/min/1.73m2: Initiation of this medicine is not recommended in patients with chronic heart failure and chronic kidney disease. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be taken orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. There are no relevant data.
This medication should not be used by certain patients. For example, individuals with allergies to the active ingredient or excipients should avoid it, as well as patients with type 1 diabetes or diabetic ketoacidosis, those with problems digesting lactose, and patients undergoing dialysis. Careful use should be exercised in patients with reduced fluid volume or kidney function issues. Since this medication can lower blood pressure or affect kidney function, fluid status and kidney function should be thoroughly checked before and after administration. In particular, patients with moderate to severe reductions in kidney function may experience diminished blood glucose control, and it is not recommended for patients with very low eGFR. While taking this medication, it is necessary to be cautious as various side effects such as genital infections, urinary tract infections, hypoglycemia, reduced fluid volume, and diabetic ketoacidosis may occur. Genital infections are more common in women, and immediate treatment should be sought if symptoms of infection appear. The risk of hypoglycemia may increase when taken with other hypoglycemic agents such as insulin or sulfonylureas, thus symptoms of hypoglycemia should be monitored, and if necessary, the dosages of these medications should be adjusted. Also, since this medication may cause a reduction in fluid volume, it is advisable to temporarily stop taking it if symptoms of dehydration or low blood pressure occur. Diabetic ketoacidosis can occur regardless of blood sugar levels, so if symptoms such as vomiting, abdominal pain, or breathing difficulties appear, immediate medical attention should be sought. This medication should also be used with caution in older adults with impaired liver or kidney function, and glucose may be detected in urine tests while taking this medication. It is safer for pregnant or breastfeeding women not to use this medication. Finally, this medication may interact with other medications, so it is important to consult with a physician or pharmacist about appropriate dose adjustments and management, especially when taking diuretics, insulin, or sulfonylureas.
vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal necrosis, hypoglycemia, decreased fluid volume, polydipsia, diabetic ketoacidosis, dizziness, constipation, xerostomia, lumbago, dysuria, polyuria, nocturia, interstitial nephritis, vulvar itching, genital itching, elevated hematocrit, initial treatment reduction in renal creatinine clearance, dyslipidemia, initial treatment increase in serum creatinine, elevated blood urea, weight loss, acute pyelonephritis, chest pain, paresthesia, cerebral infarction, nerve compression, asthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, intracerebral hemorrhage, peripheral arterial occlusion, angina pectoris, myocardial infarction, bile duct stones, cholangitis, alcoholic cirrhosis, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, chronic gastritis, diverticulosis, pneumoperitoneum, frequent bowel movements, gastroenteritis, colon polyps, intestinal perforation, epigastric discomfort, functional dyspepsia, erosive gastritis, gingival disorder, gum pain, hemorrhoids, hiatal hernia, irritable bowel syndrome, melena, chronic pancreatitis, urgency, diabetic nephropathy, overactive bladder, microalbuminuria, stress urinary incontinence, urinary hesitancy, urinary stones, abnormal urination, increased blood lactate, lymphopenia, weight gain, vitamin D deficiency, increased appetite, dysgeusia, drowsiness, tension headache, carpal tunnel syndrome, diabetic neuropathy, coma, neuralgia, peripheral neuropathy, sleep disorders, syncope, tremor, bronchitis, shingles, sinusitis, tonsillitis, diverticulitis, herpes simplex, stye, joint abscess, laryngitis, otitis media, pelvic inflammatory disease, pericoronitis, pneumonia, pulmonary tuberculosis, rhinitis, toenail fungus, herpes simplex, edema, fever, foreign body sensation, facial edema, facial pain, warmth, flu-like syndrome, fatigue, genital rash, menorrhagia, genital edema, uterine bleeding, vaginal bleeding, vulvar discomfort, menstrual irregularities, itching, urticaria, cold sweat, arthralgia, musculoskeletal pain, limb pain, myasthenia, myalgia, osteoarthritis, ligament sprain, diabetic retinopathy, cough, dyspnea, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyp, tinnitus
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or light, and it is recommended to keep it at room temperature between 1 to 30 degrees Celsius. Proper storage will maintain the medication's efficacy and ensure safe use.
Yellow, bilaterally convex, diamond-shaped film-coated tablet
100 tablets/bottle, 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDapagliflozin Bis L-proline 15.63mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Dapagliflozin Bis L-proline 7.8mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Dapagliflozin Bis L-proline 15.6mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Dapagliflozin Bis L-proline 15.63mg
Tablet · Prescription medication
Ildong Pharmaceutical Co., Ltd.

Dapagliflozin Bis L-proline 15.63mg
Tablet · Prescription medication
Boryung Pharm. Co., Ltd.
Dapagliflozin Bis L-proline 15.63mg
Tablet · Prescription medication
Jeil Pharmaceutical Co., Ltd.

Dapagliflozin Bis L-proline 7.815mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Dapagliflozin Bis L-proline 7.815mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.